発表論文一覧
| No | 試験名 | 雑誌 | 論文名 | 執筆者 |
| 2021年度(2021年4月～2021年9月)発表論文 | ||||
| 1 | LOGIK1607 | JTO Clinical and Research Reports | High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib | 大分大学 小副川 敦 |
| 2 | LOGIK0902 | ESMO Open | Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study | 岡山大学 堀田 勝幸 |
| 2020年度(2020年4月～2021年3月)発表論文 | ||||
| 1 | LOGIK1101 | The Oncologist 2020;25:1-10 |
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study | 九州がんセンター 野崎 要 |
| 2 | LOGIK0602 | BMC Cancer 2020 4;20(1):1192 |
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study | 長崎大学 土屋 智史 |
| 3 | LOGIK 1603 /WJOG 9116L | BMC Cancer (プロトコール論文) 2020 1;20(1):370 |
A Phase II Study of Osimertinib for Patients with Radiotherapy-naive CNS Metastasis of Non-Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the OCEAN Study | 長崎大学 福田 実 |
| 4 | LOGIK1604 | Eur J Cancer . 2021;149:14-22 |
Osimertinib Versus Osimertinib Plus Chemotherapy for Non-Small Cell Lung Cancer with EGFR (T790M)-Associated Resistance to Initial EGFR Inhibitor Treatment: An Open-Label, Randomized Phase 2 Clinical Trial | 九州大学 田中 謙太郎 |
| 5 | SPIRAL-Study | J. Clin. Med. 2020 5;9(6):1762 |
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment | 福岡大学 中尾 明 |
| 6 | FRABR_ABT02 | Immunological Medicine 2020 29;1-5. |
Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production | 九州大学 山田 久方 |
| 7 | CONTACT | Neurourology and Urodynamics 2020; 39: 804-12. |
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study) | 獨協医科大学病院 山西 友則 |
| 8 | GAP | Lower Urinary Tract Symptoms. 2021; 13(2):224-229. |
Prevalence of xerostomia with or without overactive bladder symptoms | 新潟大学 伊藤 加代子 |
| 9 | QUATRO Study | BMC Ophthalmology 2021 21:58 |
Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study | 九州大学 大島 裕司 |
| 10 | DIrecT Study | Urologia Internationalis 2021 9;1-9 |
Triple therapy with tamsulosin, dutasteride, and imidafenacin for benign prostatic hyperplasia in patients with overactive bladder symptoms refractory to tamsulosin: Subgroup analyses of DIrecT study | 獨協医科大学病院 山西 友則 |
| 11 | 洗浄剤 | Advances in Wound Care 2021 Mar 30. |
Effects of hand hygiene using 4% chlorhexidine gluconate or natural soap during hand rubbing followed by alcohol-based 1% chlorhexidine gluconate sanitizer lotion in the operating room | 福岡大学 秋田 定伯 |